BACKGROUND: The Ehlers-Danlos syndrome (EDS) comprises a group of hereditary connective tissue disorders. Periventricular nodular heterotopia (PNH) is a human neuronal migration disorder characterised by seizures and conglomerates of neural cells around the lateral ventricles of the brain, caused by FLNA mutations. FLNA encodes filamin A, an actin binding protein involved in cytoskeletal organisation. The amino-terminal actin binding domain (ABD) of filamins contains two tandem calponin homology domains, CHD1 and CHD2. OBJECTIVE: To report clinical and genetic analyses in a Spanish family affected by a connective tissue disorder suggestive of EDS type III and PNH. METHODS: A clinical and molecular study was undertaken in the three affected women. Clinical histories, physical and neurological examinations, brain magnetic resonance imaging studies, and skin biopsies were done. Genetic analysis of the FLNA gene was undertaken by direct sequencing and restriction fragment length polymorphism analysis. RESULTS: Mutation analysis of the FLNA gene resulted in the identification of a novel mutation in exon 3 (c.383C-->T) segregating with the combination of both syndromes. This mutation results in a substitution of an alanine residue (A128V) in CHD1. CONCLUSIONS: The findings suggest that the Ala128Val mutation causes the dual EDS-PNH phenotype. This association constitutes a new variant within the EDS spectrum. This is the first description of a familial EDS-PNH association with a mutation in FLNA.
BACKGROUND: The Ehlers-Danlos syndrome (EDS) comprises a group of hereditary connective tissue disorders. Periventricular nodular heterotopia (PNH) is a humanneuronal migration disorder characterised by seizures and conglomerates of neural cells around the lateral ventricles of the brain, caused by FLNA mutations. FLNA encodes filamin A, an actin binding protein involved in cytoskeletal organisation. The amino-terminal actin binding domain (ABD) of filamins contains two tandem calponin homology domains, CHD1 and CHD2. OBJECTIVE: To report clinical and genetic analyses in a Spanish family affected by a connective tissue disorder suggestive of EDS type III and PNH. METHODS: A clinical and molecular study was undertaken in the three affected women. Clinical histories, physical and neurological examinations, brain magnetic resonance imaging studies, and skin biopsies were done. Genetic analysis of the FLNA gene was undertaken by direct sequencing and restriction fragment length polymorphism analysis. RESULTS: Mutation analysis of the FLNA gene resulted in the identification of a novel mutation in exon 3 (c.383C-->T) segregating with the combination of both syndromes. This mutation results in a substitution of an alanine residue (A128V) in CHD1. CONCLUSIONS: The findings suggest that the Ala128Val mutation causes the dual EDS-PNH phenotype. This association constitutes a new variant within the EDS spectrum. This is the first description of a familial EDS-PNH association with a mutation in FLNA.
Authors: V L Sheen; J W Wheless; A Bodell; E Braverman; P D Cotter; K A Rauen; O Glenn; K Weisiger; S Packman; C A Walsh; E H Sherr Journal: Neurology Date: 2003-03-25 Impact factor: 9.910
Authors: E P Leeflang; S E Marsh; E Parrini; F Moro; D Pilz; W B Dobyns; R Guerrini; J W Wheless; J G Gleeson Journal: J Med Genet Date: 2003-12 Impact factor: 6.318
Authors: V L Sheen; M Topçu; S Berkovic; D Yalnizoglu; I Blatt; A Bodell; R S Hill; V S Ganesh; T J Cherry; Y Y Shugart; C A Walsh Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: P Beighton; A de Paepe; D Danks; G Finidori; T Gedde-Dahl; R Goodman; J G Hall; D W Hollister; W Horton; V A McKusick Journal: Am J Med Genet Date: 1988-03
Authors: Stephen P Robertson; Stephen R F Twigg; Andrew J Sutherland-Smith; Valérie Biancalana; Robert J Gorlin; Denise Horn; Susan J Kenwrick; Chong A Kim; Eva Morava; Ruth Newbury-Ecob; Karen H Orstavik; Oliver W J Quarrell; Charles E Schwartz; Deborah J Shears; Mohnish Suri; John Kendrick-Jones; Andrew O M Wilkie Journal: Nat Genet Date: 2003-03-03 Impact factor: 38.330
Authors: Volney L Sheen; Yuanyi Feng; Donna Graham; Toshiro Takafuta; Sandor S Shapiro; Christopher A Walsh Journal: Hum Mol Genet Date: 2002-11-01 Impact factor: 6.150
Authors: Eyal Reinstein; Sophia Frentz; Tim Morgan; Sixto García-Miñaúr; Richard J Leventer; George McGillivray; Mitchel Pariani; Anthony van der Steen; Michael Pope; Muriel Holder-Espinasse; Richard Scott; Elizabeth M Thompson; Terry Robertson; Brian Coppin; Robert Siegel; Montserrat Bret Zurita; Jose I Rodríguez; Carmen Morales; Yuri Rodrigues; Joaquín Arcas; Anand Saggar; Margaret Horton; Elaine Zackai; John M Graham; David L Rimoin; Stephen P Robertson Journal: Eur J Hum Genet Date: 2012-10-03 Impact factor: 4.246
Authors: Russell J Ferland; Luis Federico Batiz; Jason Neal; Gewei Lian; Elizabeth Bundock; Jie Lu; Yi-Chun Hsiao; Rachel Diamond; Davide Mei; Alison H Banham; Philip J Brown; Charles R Vanderburg; Jeffrey Joseph; Jonathan L Hecht; Rebecca Folkerth; Renzo Guerrini; Christopher A Walsh; Esteban M Rodriguez; Volney L Sheen Journal: Hum Mol Genet Date: 2008-11-07 Impact factor: 6.150